FDA Approves Gattex® (teduglutide [rDNA Origin]) for Injection for the Treatment of Adult Short Bowel Syndrome

Loading media player...

Download

MPEG-4
Quicktime
Windows Media

Smart Multimedia Gallery

Embed

<embed flashvars="file=http%3A%2F%2Fmms.businesswire.com%2Fbwapps%2Fmediaserver%2FViewMedia%3Fmgid%3D352153%26vid%3D19%26.mp4&image=http%3A%2F%2Fmms.businesswire.com%2Fbwapps%2Fmediaserver%2FViewMedia%3Fmgid%3D352153%26vid%3D5&provider=video&skin=http%3A%2F%2Fwww.businesswire.com%2Fflash%2Fplayer%2Fskins%2FBWGreenBar.zip"
				allowfullscreen="true"
				allowscriptaccess="always"
				id="mediaplayer1"
				name="mediaplayer1"
				src="http://www.businesswire.com/flash/player/player.swf"
				width="480"
				height="312"/>

All News | News with Multimedia > Press Release: FDA Approves Gattex® (teduglutide [rDNA Origin]...

Search News:

FDA Approves Gattex® (teduglutide [rDNA Origin]) for Injection for the Treatment of Adult Short Bowel Syndrome

Download

Smart Multimedia Gallery

View and Share Graphic

View and Share Graphic

View and Share Logo

Share

Embed

More Business Wire sites

About Us

News on BusinessWire.com

Follow Us on Twitter

Like Us on Facebook